Applied Clinical Trials Digital Edition - June 2011

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-06-01-2011
Volume 20
Issue 6

CRO/SPONSORS : Integrated Drug Safety Archiving in the United Kingdom Language and Culture in Global Trials INFORMATION TECHNOLOGY : Cloud Computing - Pharmacovigilance TRIAL DESIGN : Placebo Effect of Transdermal NSAIDs SITES : IRB Registration SUBJECT RECRUITMENT : Formula for Recruitment Success Also in this issue : e-Submissions Gain Support, Personalized Medicine, iPad Apps for Clinical Trials, R&D Productivity

External Link - article-821541.pdf

Download Issue PDF
Articles in this issue
Applied Clinical Trials Digital Edition - June 2011
i4-726495-1408617766133.jpg
Patient Recruitment Feasibility
i1-726502-1408617738386.jpg
Archiving Approach in the UK
i1-726503-1408617734282.jpg
Taking Clinical Computing in Hand
i4-726494-1408617770619.jpg
Business and News Update June 2011
i1-726492-1408617778195.jpg
Getting Personal Over Personalized Medicine
Early Use of Antiretrovirals May Reduce HIV Transmission
Moffitt Cancer Center Chooses Oracle
i1-726501-1408617741661.jpg
Current Challenges of Poor R&D
i4-726497-1408617756456.jpg
Placebo Effect of Transdermal NSAIDS
i4-726499-1408617748494.gif
Language & Culture in Global Clinical Trials
i1-726490-1408617785458.jpg
EMA Seeks to Fine-Tune Official Register
Integrated Drug Safety
Integrated Drug Safety
i1-726505-1408617726184.jpg
Strong Growth in Biopharmaceutical Approvals
i1-726498-1408617752774.jpg
FDA Gains Support for e-Submissions Standards
Recent Videos
Related Content
© FlowStudio - © FlowStudio - stock.adobe.com.

Using Data Patterns to Proactively Improve Study Quality

Sylviane de Viron;Steve Young
December 20th 2024
Article

Recent analysis showed 81% of clinical trial sites using RBQM statistical data monitoring experienced an improvement in quality.

Driving Diversity with the Integrated Research Model

Driving Diversity with the Integrated Research Model

Andy Studna, Editor
October 16th 2024
Podcast

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.

© Minerva Studio - © Minerva Studio - stock.adobe.com

Palatin Announces Positive Results From Phase IIb BREAKOUT Study

Andy Studna, Editor
December 19th 2024
Article

In patients with type 2 diabetic nephropathy, bremelanotide demonstrated efficacy in reducing urine protein to creatinine ratio and improving or stabilizing estimated glomerular filtration rate.

AI in Clinical Trials: A Long, But Promising Road Ahead

AI in Clinical Trials: A Long, But Promising Road Ahead

Miranda Schmalfuhs
May 29th 2024
Podcast

Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.

© Sebastian Kaulitzki - © Sebastian Kaulitzki - stock.adobe.com..

Teva and Sanofi Share Positive Results from Phase II Study in Ulcerative Colitis and Crohn’s Disease

Andy Studna, Editor
December 18th 2024
Article

Duvakitug, a monoclonal antibody, demonstrated clinical remission and endoscopic response in the study, meeting its primary endpoints.

Credit: Mopic | stock.adobe.com

Imlunestrant Both as Monotherapy and in Combination Shows Promising Survival Benefits for ER-Positive, HER2-Negative Advanced Breast Cancer

Davy James
December 18th 2024
Article

Results from the EMBER-3 trial show imlunestrant, both as monotherapy and in combination with Verzenio (abemaciclib), significantly improved progression-free survival in ESR1-mutated ER-positive, HER2-negative advanced breast cancer.

© 2024 MJH Life Sciences

All rights reserved.